| 영문 | oxytocin | 한글 | 옥시토신 |
|---|---|---|---|
| 설명 | 뇌의 신경뇌하수체에서 분비된다. 자궁의 수축작용을 유발하므로, 출산시에 많이 분비되어 아기가 잘 나올 수 있도록 돕는다. 또한 출산후 유방에 작용하여 젖이 나오도록, 젖샘주위의 근육을 수축하는 역할도 한다. |
||
| DDAVP, dDAVP | 1-deamino-8-D-arginine vasopressin; 1-deamino-8-N-arginine vasopressin |
|---|---|
| OCT | 1) Ornithine Carbamyl Transferase 2) Oxytocin Challenge Test |
| OCT | object classification test; optimal cutting temperature; oral contraceptive therapy; ornithine carba... |
| OT | objective test; oblique talus; occlusion time; occupational therapist, occupational therapy; ocular ... |
| OX | optic chiasma; oxacillin; oxalate; oxide; orthopedic examination; oxytocin |
| L-NAME | L-arginine and NG-nitro-L-arginine methyl ester |
|---|---|
| OT | Oxytocin |
| OX | Oxytocin |
| OXT | Oxytocin |
| OXY | Oxytocin |
| receptors, oxytocin | Cell surface proteins that bind oxytocin with high affinity and trigger intracellular changes which influence the behaviour of cells. Oxytocin receptors in the uterus and the mammary glands mediate the hormone's stimulation of contraction and milk ejection. The presence of oxytocin and oxytocin receptors in neurons of the brain probably reflects an additional role as a neurotransmitter. (12 Dec 1998) |
|---|---|
| oxytocin | <protein> A peptide hormone (1007 D) from hypothalamus: transported to the posterior lobe of the pituitary (see neurophysin). Induces smooth muscle contraction in uterus and mammary glands. Related to vasopressin. (18 Nov 1997) |
| unit of oxytocin | The oxytocic activity of 0.5 mg of the USP Posterior-pituitary Reference Standard; 1 mg of synthetic oxytocin corresponds to 500 IU. (05 Mar 2000) |
| arginine | <amino acid> An essential amino acid, a major component of proteins and contains the guanido group that has a pKa of greater than 12, so that it carries a permanent positive charge at physiological pH. It becomes an essential amino acid when the body is under stress or is in an injured state. Depressed growth results from lack of dietary arginine. Arginine deficiency syndrome is observed in human babies born with a phosphate synthetase deficiency. Normal growth and development in these infants are achieved by adding arginine to their diet. Arginine deficiency leads to carbamyl phosphate overproduction in the mitochondria due to inadequate ornithine supply. Arginine-deficient diets in males causes decreased sperm counts. Free and bound arginine are found in abundance in human male sperm and arginine has been found to stimulate sperm motility. There are two sources of arginine, arginine in the food chain and free-form arginine from supplements. Food-source arginine is found in abundance in turkey, chicken and other meats. Nonfood-source arginine is called L-arginine and is created through a fermentation process which separates arginine from all other proteins. In the presence of food and other amino acids, L-arginine will act like food-source arginine but when L-arginine is separated from its nutrient boundaries by the removal of all other amino acids, then L-arginine undertakes a different role, becoming capable of crossing the blood-brain barrier and stimulating growth hormone release secreted by the anterior pituitary. Growth hormone serum levels peak during adolescence and begin to drop after age 23. Aging reduces natural growth hormone production, which results in added body fat, reduced muscle tissue, slowed healing, lack of elasticity in the skin and reduced immune function. Human pituitary growth hormone secretion is evidenced in human males, females and children following intravenous administration of 30 grams of arginine (in 30 minutes) in adults and 0.5 grams/kilogram of bodyweight in children. Female response is somewhat higher than male response. Oral administration of L-arginine also results in the release of Human Growth Hormone. Tumour suppression is evidenced in the presence of L-arginine. In the Barbul study, tumours recurred in 100% of the control animals. But in the arginine-supplemented group, only about 60% of the tumours recurred and the animals with tumours survived longer. Supplementation of arginine in the diet inhibits development and increase in size of cancerous tumours, both chemically induced and naturally occurring. Insulin can block growth hormone release, so high serum insulin levels are counterproductive to GH release. Insulin itself is capable of stimulating muscle growth, but it also strongly stimulates fat storage. Muscle growth stimulation from insulin is minuscule compared to muscle growth stimulated by growth hormone. (13 Nov 1997) |
| arginine 2-monooxygenase | <enzyme> Catalyses oxidative decarboxylation or arginine to form gamma-guanidinobutyramide (4-guanidinobutanamide) Registry number: EC 1.13.12.1 Synonym: arginine decarboxyoxidase (26 Jun 1999) |
| arginine amidase | <enzyme> A ureahydrolase that catalyses the hydrolysis of arginine and canavanine to yield l-ornithine and urea. Chemical name: L-Arginine amidinohydrolase Registry number: EC 3.5.3.1 (12 Dec 1998) |
| arginine deiminase | <enzyme> Arginine converted to citrulline + nh3; consider also protein-arginine deiminase (EC 3.5.3.15) Registry number: EC 3.5.3.6 Synonym: arginine dihydrolase, arginine converting enzyme, arginine iminohydrolase (26 Jun 1999) |
| arginine dihydrolase | <enzyme> Arginine converted to citrulline + nh3; consider also protein-arginine deiminase (EC 3.5.3.15) Registry number: EC 3.5.3.6 Synonym: arginine dihydrolase, arginine converting enzyme, arginine iminohydrolase (26 Jun 1999) |
| arginine endopeptidase | <enzyme> Cleaves arginine at the carboxyl side in a peptide chain Registry number: EC 3.4.21.- Synonym: arginyl endopeptidase (26 Jun 1999) |
| arginine esterase | <enzyme> Probably refers to an aspect of a proteinase; also index to specific proteinase class Registry number: EC 3.1.- Synonym: me-1,arginine ester hydrolase, me-2, me 1,me 2, arginine esterase a, esterase e-ii, esterase a (26 Jun 1999) |
| arginine glutamate | A compound composed of arginine and glutamic acid, given intravenously to detoxify ammonia; used in the treatment of ammoniaemia resulting from liver dysfunction. (05 Mar 2000) |
| arginine hydrochloride | A form of arginine used for intravenous administration as an adjunct in the treatment of encephalopathies associated with liver diseases and ammoniacal azotemia. (05 Mar 2000) |
| arginine iminohydrolase | <enzyme> Arginine converted to citrulline + nh3; consider also protein-arginine deiminase (EC 3.5.3.15) Registry number: EC 3.5.3.6 Synonym: arginine dihydrolase, arginine converting enzyme, arginine iminohydrolase (26 Jun 1999) |
| arginine kinase | <enzyme> An enzyme that catalyses the phosphorylation of the guanidine nitrogen of arginine in the presence of ATP and a divalent cation with formation of phosphorylarginine and ADP. Chemical name: ATP:L-arginine N-phosphotransferase Registry number: EC 2.7.3.3 (12 Dec 1998) |
| arginine oxidase | <enzyme> Catalyses the oxidative deamination from arginine to 2-ketoarginine Registry number: EC 1.4.3.- Synonym: arginine dehydrogenase (26 Jun 1999) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|